Eric Stephen Schafer MD
Assistant Professor of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, TX
Join to View Full Profile
6701 Fannin StHouston, TX 77030
Phone+1 832-824-1000
Fax+1 410-955-0028
Dr. Schafer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Clinical Pharmacology, 2012 - 2015
Johns Hopkins Bloomberg School of Public HealthMHS, Clinical Investigation, 2011 - 2012
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2006 - 2009
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2003 - 2006- Baylor College of MedicineClass of 2003
Certifications & Licensure
TX State Medical License 2012 - 2026
MD State Medical License 2006 - 2013
PA State Medical License 2003 - 2006
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK) Start of enrollment: 2013 Aug 28
- Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate Start of enrollment: 2014 Jan 01
- Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies Start of enrollment: 2014 May 16
- Join now to see all
Publications & Presentations
PubMed
- Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeu...Nirali N Shah, Eric S Schafer, Yueh-Yun Chi, Jemily Malvar, Kenneth M Heym
Pediatric Blood & Cancer. 2025-05-01 - Intrainfusion Drug Monitoring and Algorithm-Based Dose Adjustments for Children With ALL Receiving High-Dose Methotrexate Are Feasible and Safe in Costa Rica, a Low- a...Karol Acevedo, Gabriela Soto, Mary C Shapiro, Jennifer H Foster, Kathia Valverde
JCO Global Oncology. 2025-03-01 - Delayed excretion of high-dose methotrexate in pediatric acute leukemia correlates with laxative and constipation management.Jennifer A Belsky, Ashley Chavana, Ankona Banerjee, Mark Zobeck, Eric S Schafer
Pediatric Blood & Cancer. 2025-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
